Description
Mitigating roadblocks and opening the CAR(T) door to get your patients to therapy, this final episode is designed for social workers as a part of an educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes: Improving Access and Outcomes. This CE activity includes conversations among CAR-T experts and a community clinician; it includes patient video clips and numerous downloadable resources including a directory of CAR-T treatment centers organized by state.
This activity focuses on managing logistics, improving access to CAR-T therapy for patients regardless of geography or socioeconomic status, numerous services offered by treating centers, how to overcome roadblocks for your patients including financial ones, and the need for earlier referral.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated.
Speakers
Sanjay K. Juneja, MD
Hematology, Medical Oncology
Chief of Oncology Line
Chief of Oncology Line
Baton Rouge General Hospital
Mary Bird Perkins Cancer Center
Baton Rouge, LA
Mary Bird Perkins Cancer Center
Baton Rouge, LA
Dr. Sanjay Juneja is a triple board certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, and a social & news media personality known as 'TheOncDoc' with over half a million followers. He is an active participant for the White House Healthcare Leaders in Social Media Roundtable and national speaker. Dr. Juneja is the host of an innovative podcast called 'Target: Cancer' with distinguished academicians and celebrities around the country, and been featured in several articles including The Washington Post and guested on dozens of acclaimed podcasts and regional news channels (PBS, CBS, NBC, NPR). He is a Business Report's 40 under 40 recipient from his hometown of Baton Rouge, where he partners with the LA Department of Health and Mayor's office to optimize healthcare access and outreach. Dr. Juneja currently practices in his beloved hometown of Baton Rouge Louisiana with his wife Dr. Lauren and their three wild boys.
Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX
Rayne Rouce, MD, BS, is a Pediatric Hematologist and Oncologist at Texas Children's Cancer Center where she is a member of the Leukemia and Bone Marrow Transplant Programs.
She received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston, TX, then completed fellowship at Texas Children's Hospital. Dr. Rouce has spent the past several years of her career pioneering immunotherapy research for patients with refractory leukemia and lymphoma. Specifically, she works as part of a research program (The Center for Cell and Gene Therapy at Baylor College of Medicine) focused on translating targeted T cell therapies from the bench to bedside and has been involved in every aspect of CAR T cell development for clinical use. She has significant clinical experience in taking care of patients who have received CAR T cells and is passionate about ensuring patients and families understand this exciting new therapy.
Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor in Medicine, Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies
Attending Physician, Adult BMT Service
Memorial Sloan Kettering Cancer Center
New York, NY
Sergio Giralt, M.D. - Professor of Medicine, Deputy Division Head of Hematologic Malignancies at Memorial Sloan-Kettering Cancer Center. His clinical research focus is on stem cell transplantation for patients with blood disorders. Dr Giralt trained and worked at the University of Texas M.D. Anderson Cancer Center, where he was Deputy Chair of the Department of Stem Cell Transplantation and Cellular Therapies. In May 2010, he joined the faculty of Memorial Sloan-Kettering Cancer Center to lead the Adult Bone Marrow Transplant Service and served as Chief until February 2020.
Heather DiFilippo, MSN, CRNP
Certified Adult Nurse Practitioner
University of Pennsylvania Health System
Philadelphia, PA
Heather DiFilippo, MSN, CRNP, is a Nurse Practitioner in the Department of Hematology Oncology and Bone Marrow Transplant at the Hospital of the University of Pennsylvania. She has been a nurse practitioner since 2003 and specializes in hematologic malignancies as well as bone marrow transplant and immunotherapy. She has played an active role in managing patients receiving cellular therapy since 2009 and provides ongoing patient education as well as direct patient care during and after infusion. Ms. DiFilippo attended Roanoke College in Salem, Virginia where she received a Bachelor of Science in psychology, before continuing on to pursue a Bachelor of Science in nursing at Thomas Jefferson University Hospital. While working in oncology at Jefferson University Hospital, she completed her Master of Science in nursing as well. Ms. DiFilippo is a Board-Certified Adult Nurse Practitioner and licensed in Pennsylvania.
Misha Hawkins, MSN, RN, OCN
Lead Cellular Therapy Coordinator
The University of Texas MD Anderson Cancer Center
Houston, TX
Misha Hawkins, MSN, RN, OCN is a native Houstonian. She graduated from the prestigious DeBakey High School for Health Professions and enrolled at Texas A&M University. She received her Bachelor of Science in Adult Education with an emphasis on Community Health. After working in Corporate America for over 7 years in roles that included Training Implementation Specialist and Project Manager, she decided to go to Nursing School. Misha graduated from the University of Texas Medical Branch with her Bachelor of Science in Nursing in only 11 months. Misha started working as clinical nurse at MD Anderson Cancer Center and was promoted to Clinical Charge Nurse. Misha was a part of the team that infused the first clinical trial CAR T patient at MDACC. As the approval of Standard of Care CAR T-cell Therapy approached in 2017, Misha was selected to be the first Cellular Therapy Coordinator at MD Anderson. In her current role, she has been responsible for the development of institutional processes utilized for the care, education, and management of standard of care CAR T-cell therapy patients. Misha has coordinated the care of over 275 patients among all five approved SOC CAR T therapies.
Neena Kennedy, BSN, RN, OCN™
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society
Rye Brook, NY
Neena Kennedy, BSN, RN, OCN™ is a Clinical Trial Nurse Navigator for the Leukemia and Lymphoma Society. She is part of a team of specially trained nurses focusing on educating and assisting patients with Hematological malignancies navigate and find appropriate clinical trials. Prior to joining The Leukemia & Lymphoma Society, Ms. Kennedy was a Clinical Research Nurse at the City of Hope Comprehensive Cancer Center in Duarte, California. In her role at City of Hope, she managed a portfolio of clinical trials focused on immunotherapy and novel treatments, and cared directly for patients with blood cancers participating on clinical trials. She has co-authored several research papers on Lymphoma. She received her BSN degree from Seattle University, and holds a specialty certification from the Oncology Nurse Credentialing Center. She resides in the Seattle area with her family.
Crissy Kus, BSN, RN, BMTCN
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society
Rye Brook, NY
Crissy Kus, BSN, RN, BMTCN, has spent her nursing career serving those battling blood cancer and their families. In her role at the Leukemia Lymphoma Society Crissy helps patients and their loved ones navigate the process of identifying and participating in clinical trials, and provides education, advocacy, and support through the continuum of their treatment and care. LLS is the world’s largest voluntary health agency dedicated to blood cancer. LLS’ mission is to cure leukemia, lymphoma, and myeloma, and improve the quality of life of patients and their families. Prior to LLS, Crissy managed the care of patients receiving cellular therapies, and helped build the program that provides those therapies to patients at The University of Kansas. Prior to her time at TUKHS, Crissy was a Clinical Trial Nurse Navigator at City of Hope where she managed patients receiving cellular therapies. Crissy began her career in nursing at the bedside, caring for patients and their families in their battle with blood cancers. Crissy graduated from Benedictine College with a Bachelor of Science in Nursing. She currently resides in Kansas City with her husband, their daughter, and their Great Dane.
Alejandro Marinos-Velarde, MD
Hematology-Oncology Fellow
Baylor College of Medicine
Houston, Texas
Baylor College of Medicine
Houston, Texas
Alejandro Marinos-Velarde, MD, is a Hematology-Oncology Fellow at Baylor College of Medicine in Houston, Texas. He received his medical degree from Cayetano Heredia University in Lima, Peru. He finished his internal medicine residency at William Beaumont Hospital in Royal Oak, Michigan.
Dr. Marinos Velarde has specialized training in biomedical and health informatics. His research focuses on a novel chimeric antigen receptor T-cell (CAR-T) therapy for CD30+ tumors, mainly Hodgkin lymphomas. His long-term plan is to continue his research on cellular therapies for lymphomas. He has received awards including the American Society of Hematology-Center for International Blood and Marrow Transplant Research-American Society for Transplantation and Cellular Therapy Minority Career Development award in 2021.
Elizabeth A. Weber, BSN, RN
Commercial Cellular Therapy Coordinator
University of Pennsylvania Health System
Philadelphia, PA
Elizabeth (Lizzie) Weber, BSN, RN, is the Commercial Cellular Therapy Coordinator at Penn Medicine. She received her nursing degree from Widener University. She graduated with Honors and was the recipient of the Pediatric Excellence in Care Award as well as the Undergraduate Nursing Research Award. She spent the start of her nursing career as an inpatient nurse on a Neuroscience Medical-Surgical Floor at the Hospital of the University of Pennsylvania. During this time, she was awarded “Neuroscience Nurse of the Year” and served as Unit Council Chair for a two-year term.
In her current role, Lizzie collaborates with leadership to establish organizational systems to safely provide patient care for cellular therapy candidates. She coordinates complex care for cellular therapy recipients (actual or potential) as patients navigate through the evaluation of, preparation for and care post cellular therapy infusion. She provides ongoing patient/family education based on evaluation of the individual needs of patients/families. She also participates in collaborations with manufacturers, professional organizations and other institutions to disseminate information regarding lessons learned operationalizing a Commercial Cellular Therapy Program.
Accreditation and Disclosure Information
Target Audience
This CE activity is intended for social workers engaged in the care of patients with R/R B-cell lymphomas.
Educational Objectives
After completing this CE activity, the participant should be better able to:
-
Recognize common misperceptions regarding logistics of CAR-T
-
Refer patients for consultation to determine if they are candidates for CAR-T earlier in the treatment journey
-
Identify and use resources to address logistical challenges related to CAR-T
Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Educational Partner Statement
This activity is developed with our educational partner, The Leukemia & Lymphoma Society.
Support Statement
This CE activity is supported through an educational grant from Bristol Myers Squibb.
Social Worker Continuning Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MLI maintains responsibility for the course.
Social workers completing this course receive 1.0 General Social Work continuing education credits.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Planner/Presenter
Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies
Attending Physician, Adult BMT Service
Memorial Sloan Kettering Cancer Center
New York, NY
Sergio A. Giralt, MD, FACP, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant for Actinium Pharmaceuticals, Inc., Amgen, Bristol Myers Squibb, Celgene Corporation, GlaxoSmithKline, Jazz Pharmaceuticals, Janssen Pharmaceuticals, Omeros Corporation, Pfizer Inc., and Sanofi.
Advisory Board/Consultant for Actinium Pharmaceuticals, Inc., Amgen, Bristol Myers Squibb, Celgene Corporation, GlaxoSmithKline, Jazz Pharmaceuticals, Janssen Pharmaceuticals, Omeros Corporation, Pfizer Inc., and Sanofi.
Research Grant from Actinium Pharmaceuticals, Inc, Amgen, Bristol Myers Squibb, Celgene Corporation, Janssen Pharmaceuticals, Omeros Corporation, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Company.
Planner/Presenter
Sanjay K. Juneja, MD
Hematology, Medical Oncology
Chief of Oncology Line
Baton Rouge General Hospital
Mary Bird Perkins Cancer Center
Baton Rouge, LA
Sanjay K. Juneja, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant for Gilead Sciences, Inc. and xCures.
Advisory Board/Consultant for Gilead Sciences, Inc. and xCures.
Speakers’ Bureau with AstraZeneca Pharmaceuticals and Merck & Co., Inc.
Stock Ownership with Phenomune and xCures.
Independent Contractor for xCures.
Planner/Presenter
Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX
Rayne H. Rouce, MD, BS, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant for Novartis Pharmaceuticals Corporation and Pfizer Inc.
Advisory Board/Consultant for Novartis Pharmaceuticals Corporation and Pfizer Inc.
Research Grant from Tessa Therapeutics.
Presenter
Heather DiFilippo, MSN, CRNP
Certified Adult Nurse Practitioner
University of Pennsylvania Health System
Philadelphia, PA
Heather DiFilippo, MSN, CRNP, has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Presenter
Misha Hawkins, MSN, RN, OCN
Lead Cellular Therapy Coordinator
The University of Texas MD Anderson Cancer Center
Houston, TX
Misha Hawkins, MSN, RN, OCN, has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Presenter
Crissy Kus, BSN, RN
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society
Rye Brook, NY
Crissy Kus, BSN, RN, has a financial interest/relationship or affiliation in the form of:
Speakers’ Bureau with Kite Pharma.
Speakers’ Bureau with Kite Pharma.
Presenter
Neena Kennedy, BSN, RN, OCN™
Clinical Trial Nurse Navigator
The Leukemia & Lymphoma Society
Rye Brook, NY
Neena Kennedy, BSN, RN, OCN™ has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Presenter
Alejandro Marinos-Velarde, MD
Hematology-Oncology Fellow
Baylor College of Medicine
Houston, TX
Alejandro Marinos-Velarde, MD, has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Presenter
Elizabeth A. Weber, BSN, RN
Commercial Cellular Therapy Coordinator
University of Pennsylvania Health System
Philadelphia, PA
Elizabeth A. Weber, BSN, RN, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant for Janssen Pharmaceuticals and Novartis Pharmaceuticals Corporation.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Patient/Planner/Presenter
Laurie Adami
Laurie Adami has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Patient/Planner/Presenter
Sonia Su
Sonia Su has no relevant financial relationship with ineligible companies to disclose for this educational activity.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider and The Leukemia & Lymphoma Society, the joint provider do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
Planner
Lauren Berger, MPH
The Leukemia & Lymphoma Society
Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:
Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
About This Activity
Medical Learning Institute, Inc. and The Leukemia and Lymphoma Society are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and The Leukemia and Lymphoma Society.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2022 Medical Learning Institute, Inc | All Rights Reserved